✦ LIBER ✦

36 Pegylated liposomal doxorubicine (Caelyx®) in the treatment of advanced or metastatic soft tissue sarcoma in the elderly patient – a single center analysis

✍ Scribed by Wolter, P.; Luyten, D.; Wildiers, H.; Dumez, H.; Van Oosterom, A.; Schöffski, P.

Book ID: 123173193
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 46 KB
Volume: 60
Category: Article
ISSN: 1040-8428
DOI: 10.1016/S1040-8428(13)70107-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised phase II trial of pegylated l

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

✍ I Judson; J.A Radford; M Harris; J.-Y Blay; Q van Hoesel; A le Cesne; A.T van Oo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Phase 1 European Organisation for Resear

Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx®) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas

✍ O.S. Nielsen; P. Reichardt; T.B. Christensen; D. Pink; S. Daugaard; C. Hermans; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Combination of pegylated liposomal doxor

Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group

✍ Bafaloukos, D; Papadimitriou, C; Linardou, H; Aravantinos, G; Papakostas, P; Ska 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 105 KB

Pegylated liposomal doxorubicin as secon

Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma : A retrospective study

✍ Giuseppe Di Lorenzo; Rossella Di Trolio; Vincenzo Montesarchio; Giovanna Palmier 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND. Classic Kaposi sarcoma (CKS) is a rare neoplasm that predominantly occurs in elderly subjects and has a variable clinical evolution. The clinical course is usually indolent, but occasionally the neoplasm progresses rapidly and spreads to internal organs, necessitating sy

695 An EORTC phase I study to determine

695 An EORTC phase I study to determine the safety of combined caelyx and ifosfamide in previously untreated adult patients with advanced or metastatic soft tissues sarcomas

✍ O.S. Nielsen; P. Reichardt; D. Pink; J. Lindegaard; S. Daugaard; C. Hermans; M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

1188 ORAL Final data of the EORTC phase

1188 ORAL Final data of the EORTC phase 1 study determining safety of Caelyx in combination with lfosfamide in previously untreated adult patients with advanced or metastatic soft tissues sarcomas

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB